Nazol nasal spray 0.05% 10 ml — Made in Germany — Free Delivery

Pharmacodynamics. Oxymetazoline hydrochloride is a synthetic adrenergic agonist. stimulating α-adrenergic receptors of blood vessels, it promotes a pronounced and prolonged vasoconstrictor effect the vasoconstrictor effect is manifested by a decrease in blood flow, a decrease in edema of the mucous membranes of the nose, paranasal sinuses and the Eustachian tube, as a result of which breathing through the nose is restored, which was disturbed by flu, colds and allergic diseases.

Local vasoconstriction of the nasal mucosa and paranasal sinuses occurs 5–10 minutes after injection of the preparation  into the nasal cavity. The decongestant effect lasts up to 12 hours. The preparation has a softening effect on the irritated mucous membrane of the nasal passages and protects it from excessive drying.

Pharmacokinetics. T½ oxymetazoline hydrochloride is 5-8 hours. It is excreted mainly unchanged in the urine and feces.

Symptomatic treatment of colds, flu, allergic diseases (hay fever), accompanied by acute rhinitis, sinusitis, other sinusitis (frontal sinusitis, ethmoiditis), acute otitis media.

Adults and children from the age of 12 years to do 2 injections, children from 6 to 12 years old - 1 injection in each nasal passage. the bottle should be held upright. repeat the injection no earlier than 12 hours later.

The duration of treatment is no more than 3 days. Longer use is possible - up to 7-10 days, 2 injections per day under the supervision of a physician.

Hypersensitivity to oxymetazoline, other adrenomimetics or other components of the preparation, severe forms of ages, severe atherosclerosis, acute cardiovascular diseases or cardiac asthma, tachysystolic heart rhythm disturbances, angina pectoris, renal failure, severe prostatic hypertrophy, pheochromocytoma, metabolic disorders , diabetes mellitus), atrophic rhinitis, increased intraocular pressure, especially in angle-closure glaucoma, after transsphenoidal hypophysectomy or other surgical intervention with the opening of the dura mater, patients with inflammation or damage to the skin around the nasal passages or nasal mucosa, the use of preparations that increase blood pressure ; simultaneous use with MAO inhibitors and use within 2 weeks after stopping treatment with MAO inhibitors.

With frequent and prolonged use, there may be sensations of burning, tingling in the nose, flushing of the face, sneezing, dryness of the nasal mucosa. rarely - after the effect of the preparation is over, - a feeling of severe nasal congestion (reactive hyperemia). long-term continuous use of vasoconstrictor preparations can lead to tachyphylaxis or the development of rhinitis medicamentosa. in general, severe side effects are not expected.

On the part of the cardiovascular system. Tachycardia, palpitations, increased blood pressure, heart pain are very rare.

On the part of the organ of vision. Rarely, there may be eye irritation, discomfort or redness, and blurred vision.

From the gastrointestinal tract. Rarely, nausea may occur.

From the immune system. In rare cases, hypersensitivity reactions are possible, including rash, itching, Quincke's edema.

Disturbances from the respiratory system, chest and mediastinal organs. Rarely, there may be discomfort or irritation in the nose, mouth, throat, and nosebleeds.

From the nervous system. Anxiety, nervousness, anxiety, insomnia, drowsiness, tremors, hallucinations (especially in children), increased fatigue, headache, dizziness.

Skin and subcutaneous tissue disorders. Rash.

Skeletal muscle and connective tissue disorders. Convulsions (especially in children).

General violations. Weakness.